Numerous studies have identified characteristic lncRNA profiles in age ≥ 60 CN-AML patients with recurrent genetic mutations such as FLT3-ITD, NPM1, CEBPA, and RUNX1 mutations. The gene discussed is NPM1; the disease is acute myeloid leukemia.